Medtronic's Collins confident of 15% CAGR (compounded annual growth rate) - without acquisitions
This article was originally published in Clinica
Executive Summary
Medtronic unveiled its five-year plan for growth yesterday, telling analysts that despite its size and dominance of the medical device market it will comfortably achieve a 15% compounded annual growth rate by focusing on its potentially large but still under-penetrated major markets.